EPIB301_W7L1_Keralis (1)

Cohort Studies Overview

  • Definition: Cohort studies involve following a group of individuals (cohort) over time to assess outcomes based on specific exposures.

Roadmap

  • Overview of cohort study.

  • Study timing: distinguishing between prospective, retrospective, and ambidirectional cohorts.

  • Types of cohorts: population-based and exposure-based.

  • Selecting a comparison group for assessment.

  • Importance of follow-up with study subjects.

  • Strengths and weaknesses of cohort studies.

  • Understanding risk vs. odds.

  • Calculating relative risk and attributable risk.

Epidemiologic Study Designs

  • Observational Studies: Analyzed without manipulation of exposure.

    • Types:

      • Analytic Studies: Case-control, cohort.

      • Descriptive Studies: Case reports, case series.

  • Experimental Studies: Involve manipulation of exposure via Randomized Controlled Trials (RCT) and Quasi-experimental methods.

Observational vs. Experimental Studies

  • Experimental Studies:

    • Involve exposure manipulation, i.e., RCT (randomization) and quasi-experimental designs (no randomization).

  • Observational Studies:

    • Measurement of exposures without direct manipulation by the researcher.

Cohort Study Design

  • Selection Process:

    • Identify subjects based on exposure (present vs. absent).

    • Follow subjects over time to assess disease incidence.

  • Comparison of risk ratios in exposed vs. non-exposed groups.

Timing of Cohort Studies

  • Prospective Cohort:

    • Initiated in the present, follows participants into the future.

    • Advantages: Better data collection, lower bias.

    • Disadvantages: More expensive, time-consuming.

  • Retrospective Cohort:

    • Looks back at data from the past.

    • Advantages: Cheaper, faster; efficient for long-latency diseases.

    • Disadvantages: Potentially inadequate data, higher bias.

  • Ambidirectional Cohort:

    • Combines elements from both prospective and retrospective studies.

Types of Cohorts

  • Population-based Cohorts:

    • Investigate common exposures in the general population (e.g., Framingham Heart Study).

  • Exposure-based Cohorts:

    • Focus on rare or unusual exposures (e.g., Vietnam veterans exposed to Agent Orange).

Special Cohorts Example: Agent Orange Study

  • Objective: Evaluate health effects related to Agent Orange exposure among Air Force personnel.

  • Follow a cohort of 2,483 veterans, assessing outcomes against a comparison group.

Selection of Comparison Group

  • Counterfactual Ideal:

    • Accurate comparison represents those in the exposed group had they not been exposed.

  • Importance of selecting a group similar in other risk factors.

Follow-Up in Cohort Studies

  • Participants may exit due to:

    • Disease development.

    • Death.

    • Study completion.

  • Importance of minimizing loss to follow-up to maintain study validity.

Strategies to Minimize Loss to Follow-Up

  • Begin with an interested cohort, collect identifiable info (name, contact).

  • Use various communication methods: mail, phone, social media.

  • Incentivize participation, keep questionnaires concise.

Strengths and Weaknesses of Cohort Studies

  • Strengths:

    • Primary method for estimating incidence.

    • Clear temporal exposure-disease relationship.

    • Can assess multiple outcomes.

  • Weaknesses:

    • Logistically complex and potentially expensive.

    • Risk of loss to follow-up.

Risk vs. Odds

  • Risk:

    • Probability of developing a specified health outcome.

  • Odds:

    • Ratio of probability of developing an outcome vs. not developing it.

  • Understanding and interpreting risk ratios in context of exposure.

Calculating Relative Risk

  • Risk Ratio Formula: ( \text{Risk Ratio} = \frac{CIE}{CIU} )

    • Where CIE = cumulative incidence in exposed; CIU = cumulative incidence in unexposed.

Interpreting Risk Ratios

  • RR > 1: Positive association between exposure and disease.

  • RR = 1: No association.

  • RR < 1: Indicates protective effect of exposure.

Attributable Risk

  • Definition: Excess risk among the exposed due to the exposure.

  • Attributable Risk Percent: Proportion of disease in the exposed group due to exposure.

Calculating and Interpreting Attributable Risk

  • AR Formula: ( AR = CIE - CIU )

  • Interpretation Examples: Describing additional cases potentially preventable if exposure eliminated.

Conclusion

  • Importance of reading Chapter 8 before the next class for continuation on experimental studies.